{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:12:05Z","timestamp":1792681925112,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to assess the trends and outcomes of fertility preservation (FP) in women referred for FP counseling and presenting with pregnancy-associated cancer (PAC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This is a prospective cohort study of all patients referred for FP counseling between 2001 and 2024 to the FP program of Karolinska University Hospital, Sweden. Baseline data, age, parity, disease stage, treatment characteristics, and FP methods were retrieved from clinical registries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 50 women with cancer diagnosed coincidentally with pregnancy (79%) or up to 1 year after delivery (21%) were referred for FP counseling. Among them, 30 women chose to proceed with FP; 10 by either hormonal stimulation to freeze eggs\/embryos or ovarian tissue cryopreservation (OTC) after abortion\/miscarriage, 10 by OTC at delivery, and 9 were planned for FP postpartum. The most common cancers were breast cancer (\n                      <jats:italic>N<\/jats:italic>\n                      = 31, 62%), cervical cancer (\n                      <jats:italic>N<\/jats:italic>\n                      = 6, 12%), and lymphoma (\n                      <jats:italic>N<\/jats:italic>\n                      = 5, 10%). Most women diagnosed with cancer in the first trimester either terminated the pregnancy or had a miscarriage (76%). All patients diagnosed in the second and third trimesters delivered through cesarian section (\n                      <jats:italic>N<\/jats:italic>\n                      = 14), scheduled from week 31 and onwards. All patients diagnosed in the third trimester started cancer treatment postpartum. In the FP group, 57% cryopreserved ovarian tissue postpartum or post-abortion and 43% underwent ovarian stimulation for oocyte\/embryo cryopreservation prior to chemotherapy initiation. Four women proceed to FP after chemotherapy, three by ovarian tissue freezing and one through attempted, unsuccessful, hormonal stimulation. After a mean follow-up of 9.9 years, 45 patients were alive. The proportion of women having previous children at diagnosis was the same among the FP and no-FP groups. At the end of follow-up, the percentage of nulliparous women was 20% in the no-FP group and 13% in the FP group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our observations underscore the need to ensure good multidisciplinary communication to inform patients presenting with PAC on the future risk for infertility and on the available FP procedures. As FP has to be applied when the patients are not pregnant, these measures can be planned in connection with a cesarean section, or after completion of cancer treatment. Current guidelines for FP lack specific recommendations for women with PAC, and specialized PAC guidelines also lack specific information on FP. Clinical Trial Registration: ClinicalTrials.gov, identifier NTC04602962.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1771764","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T05:18:36Z","timestamp":1771219116000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends and outcomes of fertility preservation in patients presenting with cancer during pregnancy or postpartum\u2014a longitudinal observational cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Hanna P.","family":"Nilsson","sequence":"first","affiliation":[{"name":"Department of Oncology-Pathology, Laboratory of Translational Fertility Preservation, Karolinska Institutet","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riikka","family":"Bornhede","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Laboratory of Translational Fertility Preservation, Karolinska Institutet","place":["Stockholm, Sweden"]},{"name":"Department of Women\u2019s Health, Division of Obstetrics, Karolinska University Hospital","place":["Huddinge, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L. V.","family":"Johansson","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenny A.","family":"Rodriguez-Wallberg","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Laboratory of Translational Fertility Preservation, Karolinska Institutet","place":["Stockholm, Sweden"]},{"name":"Department of Reproductive Medicine, Division of Gynecology and Reproduction,Karolinska University Hospital","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1714394","article-title":"Cancer and pregnancy: national trends","volume":"39","author":"Ma","year":"2022","journal-title":"Am J Perinatol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182a057a2","article-title":"Incidence of pregnancy-associated cancer in Denmark, 1977-2006","volume":"122","author":"Eibye","year":"2013","journal-title":"Obstet Gynecol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061356","article-title":"Frequency of pregnancy-associated cancer: A systematic review of population-based studies","volume":"12","author":"Dalmartello","year":"2020","journal-title":"Cancers (Basel)."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14677","article-title":"Risk factors for the increasing incidence of pregnancy-associated cancer in Sweden - a population-based study","volume":"103","author":"Lundberg","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.2002-0279","article-title":"Coexistence of pregnancy and Malignancy","volume":"7","author":"Pavlidis","year":"2002","journal-title":"Oncologist."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001776","article-title":"Management of pregnancy in women with cancer","volume":"31","author":"Wolters","year":"2021","journal-title":"Int J Gynecol Cancer."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14653","article-title":"Cancer in pregnancy\u2009-\u2009The obstetrical management","volume":"103","author":"Storgaard","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12884-023-06182-4","article-title":"Neonatal outcomes and follow-up of children born to women with pregnancy-associated cancer: a prospective observational study","volume":"24","author":"Capozza","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"B9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejca.2020.07.004","article-title":"International Network on Cancer, Infertility and Pregnancy (INCIP). Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy","volume":"138","author":"Vandenbroucke","year":"2020","journal-title":"Eur J Cancer."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02005","article-title":"Cognitive and behavioral development of 9-year-old children after maternal cancer during pregnancy: A prospective multicenter cohort study","volume":"41","author":"Van Assche","year":"2023","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2009.11.007","article-title":"Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy","volume":"36","author":"Azim","year":"2010","journal-title":"Part I: solid tumors. Cancer Treat Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70363-1","article-title":"Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study","volume":"13","author":"Amant","year":"2012","journal-title":"Lancet Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoaa052","article-title":"ESHRE guideline: female fertility preservation","volume":"2020","author":"Anderson","year":"2020","journal-title":"Hum Reprod Open"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1200\/JCO-25-01373","article-title":"Fertility preservation in people with cancer: ASCO guideline update","volume":"43","author":"Su","year":"2025","journal-title":"J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35108","article-title":"Fertility preservation before and after cancer treatment in children, adolescents, and young adults","volume":"130","author":"Yang","year":"2024","journal-title":"Cancer."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1970","article-title":"The experience of pregnancy and early motherhood in women diagnosed with gestational breast cancer","volume":"21","author":"Ives","year":"2012","journal-title":"Psychooncology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e13214","DOI":"10.1111\/ecc.13214","article-title":"Motherhood during or after breast cancer diagnosis: A qualitative study","volume":"29","author":"Faccio","year":"2020","journal-title":"Eur J Cancer Care (Engl)."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.620353","article-title":"Lights and shadows\u201d: an interpretative phenomenological analysis of the lived experience of being diagnosed with breast cancer during pregnancy","volume":"12","author":"Facchin","year":"2021","journal-title":"Front Psychol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1926","article-title":"The psychological impact of a cancer diagnosed during pregnancy: determinants of long-term distress","volume":"21","author":"Henry","year":"2012","journal-title":"Psychooncology."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.01.159","article-title":"Web-based survey of fertility issues in young women with breast cancer","volume":"22","author":"Partridge","year":"2004","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/(sici)1097-0142(19990815)86:4<697::aid-cncr20>3.0.co;2-j","article-title":"Having children after cancer. A pilot survey of survivors\u2019 attitudes and experiences","volume":"86","author":"Schover","year":"1999","journal-title":"Cancer."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13559","article-title":"A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients\u2019 choices and benefit of the chosen methods after long-term follow up","volume":"98","author":"Rodriguez-Wallberg","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2024.02.002","article-title":"Pregnancy-associated cancer: A systematic review and meta-analysis","volume":"8","author":"Walters","year":"2024","journal-title":"Mayo Clin Proc Innov Qual Outcomes."},{"key":"B24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ygyno.2025.11.007","article-title":"Obstetric and perinatal outcomes following a diagnosis of gynecologic cancer\u00a0during pregnancy","volume":"204","author":"Shi","year":"2025","journal-title":"Gynecol Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14555","article-title":"Risk of obstetric and perinatal complications in women presenting with breast cancer during pregnancy and the first year postpartum in Sweden 1973-2017: A population-based matched study","volume":"103","author":"Lundberg","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.3677","article-title":"Relapse rates and disease-specific mortality following procedures for fertility preservation at time of breast cancer diagnosis","volume":"8","author":"Marklund","year":"2022","journal-title":"JAMA Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/aogs.15007","article-title":"The complexity and challenges of fertility preservation in women with cervix cancer-A prospective cohort study reporting on reproductive outcome and overall survival","volume":"104","author":"Marklund","year":"2025","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17074","article-title":"Cancer in pregnancy and the risk of adverse pregnancy and neonatal outcomes:\u00a0A\u00a0nationwide cohort study","volume":"129","author":"Greiber","year":"2022","journal-title":"BJOG."},{"key":"B29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11912-020-0862-7","article-title":"International network on cancer, infertility and pregnancy (INCIP). Pregnancy and cancer: the INCIP project","volume":"22","author":"Maggen","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4087","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","volume":"371","author":"Hanna","year":"2020","journal-title":"BMJ."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.01.030","article-title":"Random-start con- trolled ovarian hyperstimulation for emergency fertility preserva- tion in letrozole cycles","volume":"95","author":"Sonmezer","year":"2011","journal-title":"Fertil Steril."},{"key":"B32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.fertnstert.2012.09.028","article-title":"Mature oocyte cryopreservation: A guideline","volume":"99","year":"2013","journal-title":"Fertil Steril"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2019.09.013","article-title":"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion","volume":"112","author":"Practice Committee","year":"2019","journal-title":"Fertil Steril"},{"key":"B34","unstructured":""}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1771764\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T05:18:37Z","timestamp":1771219117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1771764\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":34,"alternative-id":["10.3389\/fendo.2026.1771764"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1771764","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"article-number":"1771764"}}